A Hierarchical Training Paradigm for Antibody Structure-sequence Co-design

Fang Wu,Stan Z. Li
2023-10-30
Abstract:Therapeutic antibodies are an essential and rapidly expanding drug modality. The binding specificity between antibodies and antigens is decided by complementarity-determining regions (CDRs) at the tips of these Y-shaped proteins. In this paper, we propose a hierarchical training paradigm (HTP) for the antibody sequence-structure co-design. HTP consists of four levels of training stages, each corresponding to a specific protein modality within a particular protein domain. Through carefully crafted tasks in different stages, HTP seamlessly and effectively integrates geometric graph neural networks (GNNs) with large-scale protein language models to excavate evolutionary information from not only geometric structures but also vast antibody and non-antibody sequence databases, which determines ligand binding pose and strength. Empirical experiments show that HTP sets the new state-of-the-art performance in the co-design problem as well as the fix-backbone design. Our research offers a hopeful path to unleash the potential of deep generative architectures and seeks to illuminate the way forward for the antibody sequence and structure co-design challenge.
Biomolecules,Computational Engineering, Finance, and Science,Machine Learning
What problem does this paper attempt to address?
The paper aims to address the problem of co-designing antibody sequences and structures. Specifically, it proposes a Hierarchical Training Paradigm (HTP) for the co-design of antibody sequences and structures. HTP consists of 4 distinct training stages, each corresponding to specific protein patterns within particular protein domains. Through carefully designed tasks, HTP seamlessly integrates geometric graph neural networks (GNN) with large-scale protein language models to extract evolutionary information from geometric structures and extensive databases of antibody and non-antibody sequences, thereby determining the binding pose and strength of ligands. Experimental results show that HTP achieves new state-of-the-art performance in the co-design problem and also significantly improves the fixed backbone design problem. This study provides hope for further exploring the potential of deep generative architectures and points the way for future challenges in the co-design of antibody sequences and structures.